Matt Larew
Stock Analyst at William Blair
(4.57)
# 973
Out of 4,634 analysts
212
Total ratings
61.7%
Success rate
16.4%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Maintained: Hold | n/a | $43.85 | - | 2 | Aug 7, 2026 | |
| NTRA Natera | Reiterated: Buy | n/a | $318.35 | - | 1 | Aug 7, 2026 | |
| TXG 10x Genomics | Maintained: Buy | n/a | $58.57 | - | 10 | Aug 7, 2026 | |
| MRVI Maravai LifeSciences Holdings | Reiterated: Hold | n/a | $6.07 | - | 14 | Aug 7, 2026 | |
| BDSX Biodesix | Reiterated: Buy | n/a | $24.86 | - | 1 | Aug 6, 2026 | |
| TKNO Alpha Teknova | Maintained: Buy | n/a | $6.72 | - | 9 | Aug 6, 2026 | |
| BLLN BillionToOne | Maintained: Buy | n/a | $98.65 | - | 1 | Aug 6, 2026 | |
| STVN Stevanato Group | Maintained: Buy | n/a | $20.58 | - | 13 | Aug 5, 2026 | |
| WAT Waters | Maintained: Buy | n/a | $411.77 | - | 6 | Aug 4, 2026 | |
| CDNA CareDx | Rated: Hold | n/a | $47.07 | - | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $124.88 | - | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $133.68 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $46.27 | - | 1 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $167.21 | - | 2 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $55.06 | - | 2 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.45 | - | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.50 | - | 13 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.63 | - | 1 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.73 | - | 9 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $163.17 | - | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $599.69 | - | 11 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $352.13 | - | 12 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $209.37 | - | 9 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.21 | - | 10 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $72.12 | - | 8 | Jun 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.65 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.80 | - | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $277.00 | - | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $81.74 | n/a | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.08 | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.90 | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $183.69 | n/a | 4 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $321.31 | n/a | 1 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $125.81 | n/a | 1 | Nov 21, 2017 |
Qiagen
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $43.85
Upside: -
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $318.35
Upside: -
10x Genomics
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $58.57
Upside: -
Maravai LifeSciences Holdings
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.07
Upside: -
Biodesix
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.86
Upside: -
Alpha Teknova
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $6.72
Upside: -
BillionToOne
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $98.65
Upside: -
Stevanato Group
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $20.58
Upside: -
Waters
Aug 4, 2026
Maintained: Buy
Price Target: n/a
Current: $411.77
Upside: -
CareDx
Aug 3, 2026
Rated: Hold
Price Target: n/a
Current: $47.07
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $124.88
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $133.68
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $46.27
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $167.21
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $55.06
Upside: -
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $25.45
Upside: -
Jul 29, 2026
Maintained: Buy
Price Target: n/a
Current: $24.50
Upside: -
Jul 29, 2026
Maintained: Hold
Price Target: n/a
Current: $16.63
Upside: -
Jul 29, 2026
Rated: Hold
Price Target: n/a
Current: $13.73
Upside: -
Jul 28, 2026
Maintained: Buy
Price Target: n/a
Current: $163.17
Upside: -
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $599.69
Upside: -
Jul 23, 2026
Maintained: Buy
Price Target: n/a
Current: $352.13
Upside: -
Jul 22, 2026
Maintained: Buy
Price Target: n/a
Current: $209.37
Upside: -
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $1.21
Upside: -
Jun 27, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.12
Upside: -
May 11, 2026
Reiterated: Sell
Price Target: n/a
Current: $7.65
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.80
Upside: -
Oct 11, 2025
Upgraded: Buy
Price Target: n/a
Current: $277.00
Upside: -
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $81.74
Upside: n/a
Aug 22, 2022
Maintained: Buy
Price Target: n/a
Current: $15.08
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $10.90
Upside: n/a
Sep 11, 2019
Downgraded: Hold
Price Target: n/a
Current: $183.69
Upside: n/a
Dec 3, 2018
Maintained: Buy
Price Target: n/a
Current: $321.31
Upside: n/a
Nov 21, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $125.81
Upside: n/a